Çocuklarda hipolipidemiler

Plazma lipoprotein düzeylerinin düşüklüğü ile karşımıza çıkan hipolipidemiler primer (genetik) veya sekonder (kazanılmış) nedenlere bağlı olabilir. Hiperlipidemilerin aksine, hipolipidemilerin neden ve sonuçları konularında klinisyenlerin farkındalığı çoğu zaman yeterli olmamaktadır. Bununla birlikte, hipolipidemiler altta yatan ciddi bir sorunun göstergesi olabilir. Açıklanamayan hipolipidemilerin olası nedenleri kesinlikle araştırılmalıdır. Bu makalede, çocuklarda primer ve sekonder hipolipidemilerin nedenleri ve mekanizmaları tartışılmıştır.

Hypolipodemias in children

Hypolipidemia is defined as a decrease in plasma lipoprotein caused by primary (genetic) or secondary (acquired) factors. Unlike hyperlipidemia, physicians are usually inadequately aware of hypolipidemia, its causes and consequences. However, hypolipidemias can be a marker for an underlying, serious problem. Unexplained hypolipidemias should always be investigated for their possible causes. In this report, causes and mechanisms of primary and secondary hypolipidemias in children were discussed.

Kaynakça

1. Wilson RF, Barletta JF, Tyburski JG. Hypocholesterolemia in sepsis and critically il lor injured patients. Crit Care 2003;7:413-414. http://dx.doi.org/10.1186/cc2390

2. Tershakovec AM, Rader DJ. Disorders of lipoprotein metabolism and transport. In. Nelson. Textbook of Pediatrics. Behram RW, Kliegman RM, Jenson HB, Stanton BF (eds). Nelson Textbook of Pediatrics. 17th ed, Philadelphia, Saunders 2004: 445-459.

3. Glueck CJ, Kelley W, Gupta A, Fontaine RN, Wang P, Gartside PS. Prospective 10-year evaluation of hypobetalipoproteinemia in a cohort of 772 firefighters and crosssectional evaluation of hypocholesterolemia in 1,479 men in the National Health and Nutrition Examination Survey I. Metabolism 1997;46:625-633. http://dx.doi.org/10.1016/S0026-0495(97)90004-4

4. Oster P, Muchowski H, Heuck CC, Schlierf G. The prognostic significance of hypocholesterolemia in hospitalized patients. Klin Wochenschr 1981;59:857-860. http://dx.doi.org/10.1007/BF01721056

5. Lévesque H, Gancel A, Pertuet S, Czernichow P, Courtois H. Hypocholesterolemia: prevalence, diagnostic and prognostic value. Study in a department of internal medicine. Presse Med 1991;20:1935-1938.

6. Windler E, Ewers-Grabow U, Thiery J, Walli A, Seidel D, Greten H. The prognostic value of hypocholesterolemia in hospitalized patients. Clin Investig 1994;72:939-943. http://dx.doi.org/10.1007/BF00577732

7. Crook MA, Velauthar U, Moran L, Griffiths W. Hypocholesterolaemia in a hospital population. Ann Clin Biochem 1999;36:613-616. http://dx.doi.org/10.1177/000456329903600508

8. Yokoyama M, Suto Y, Sato H, Arai K, Waga S, Kitazawa J, Maruyama H, Ito E. Low serum lipids suggest severe bone marrow failure in children with aplastic anemia. Pediatr Int 2000;42:613-619. http://dx.doi.org/10.1046/j.1442-200x.2000.01310.x

9. Bjerve KS, Evensen SA, Stray-Pedersen S, Skrede S. On the pathogenesis of acquired hypo-beta-lipoproteinemia. A case associated with sideroblastic anemia. Acta Med Scand 1982;211:313-318. http://dx.doi.org/10.1111/j.0954-6820.1982.tb01953.x

10. Asai K, Kuzuya M, Naito M, Funaki C, Kuzuya F. Effects of splenectomy on serum lipids and experimental atherosclerosis. Angiology 1988;39:497-504. http://dx.doi.org/10.1177/000331978803900602

11. Giovannini I, Boldrini G, Chiarla C, Giuliante F, Vellone M, Nuzzo G. Pathophysiologic correlates of hypocholesterolemia in critically ill surgical patients. Intensive Care Med 1999;25:748-751. http://dx.doi.org/10.1007/s001340050940

12. Ettinger WH, Sun WH, Binkley N, Kouba E, Ershler W. Interleukin-6 causes hypocholesterolemia in middle-aged and old rhesus monkeys. J Gerontol A Biol Sci Med Sci 1995;50:137-140. http://dx.doi.org/10.1093/gerona/50A.3.M137

13. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998;32:107-114. http://dx.doi.org/10.1053/ajkd.1998.v32.pm9669431

14. Ripollés Piquer B, Nazih H, Bourreille A, Segain JP, Huvelin JM, Galmiche JP, Bard JM. Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system. Metabolism 2006;55:980-988. http://dx.doi.org/10.1016/j.metabol.2006.03.006

15. Noseda G. Anti-lipoprotein autoantibodies with hypolipidemi in infectious rheumatism. Schweiz Med Wochenschr 1975;105:1-58.

16. Chiarla C, Giovannini I, Siegel JH. The relationship between plasma cholesterol, amino acids and acute phase proteins in sepsis. Amino Acids 2004;27:97-100. http://dx.doi.org/10.1007/s00726-004-0064-x

17. Peterson C, Vitols S, Rudling M, Blomgren H, Edsmyr F, Skoog L. Hypocholesterolemia in cancer patients may be caused by elevated LDL receptor activities in malignant cells. Med Oncol Tumor Pharmacother 1985;2:143-147.

18. D'Arienzo A, Manguso F, Scaglione G, Vicinanza G, Bennato R, Mazzacca G. Prognostic value of progressive decrease in serum cholesterol in predicting survival in Child-Pugh C viral cirrhosis. Scand J Gastroenterol 1998;33:1213-1218. http://dx.doi.org/10.1080/00365529850172593

19. Liberopoulos EN, Elisaf MS. Dyslipidemia in patients with thyroid disorders. Hormones 2002;1:218-223. http://dx.doi.org/10.14310/horm.2002.1170

20. Kung A, Pang R, Lander I, Lam K, Janus E. Changes in serum lipoprotein (a) and lipids during treatment of hyperthyroidism. Clin Chem 1995;41:226-231.

21. Bentz MH, Magnette J. Hypocholesterolemia during the acute phase of an inflammatory reaction of infectious origin. 120 cases. Rev Med Interne 1998;19:168-172. http://dx.doi.org/10.1016/S0248-8663(97)80715-1

22. Brar P, Kwon GY, Holleran S, Bai D, Tall AR, Ramakrishnan R, Green PH. Change in lipid profile in celiac disease: beneficial effect of gluten-free diet. Am J Med 2006;119:786-790. http://dx.doi.org/10.1016/j.amjmed.2005.12.025

23. Tarugi P, Averna M, Di Leo E, Cefalù AB, Noto D, Magnolo L, Cattin L, Bertolini S, Calandra S. Molecular diagnosis of hypobetalipoproteinemia: an ENID review. Atherosclerosis 2007;195:19-27. http://dx.doi.org/10.1016/j.atherosclerosis.2007.05.003

24. Zamel R, Khan R, Pollex RL, Hegele RA. Abetalipoproteinemia: two case reports and literature review. Orphanet J Rare Dis 2008;3:19. http://dx.doi.org/10.1186/1750-1172-3-19

25. Seckeler MD, Linden J. Maternal abetalipoproteinemia resulting in multiple fetal anomalies. Neonatology 2008;94:310-313. http://dx.doi.org/10.1159/000151653

26. Berriot-Varoqueaux N, Aggerbeck LP, Samson-Bouma M, Wetterau JR. The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annu Rev Nutr 2000;20:663-697. http://dx.doi.org/10.1146/annurev.nutr.20.1.663

27. Hooper AJ, van Bockxmeer FM, Burnett JR. Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism. Crit Rev Clin Lab Sci 2005;42:515-545. http://dx.doi.org/10.1080/10408360500295113

28. Lancellotti S, Zaffanello M, Di Leo E, Costa L, Lonardo A, Tarugi P. Pediatric gallstone disease in familial hypobetalipoproteinemia. J Hepatol 2005;43:188-191. http://dx.doi.org/10.1016/j.jhep.2005.03.012

29. Peretti N, Roy CC, Sassolas A, Deslandres C, Drouin E, Rasquin A, Seidman E, Brochu P, Vohl MC, Labarge S, Bouvier R, Samson-Bouma ME, Charcosset M, Lachaux A, Levy E. Chylomicron retention disease: a long term study of two cohorts. Mol Genet Metab 2009;97:136-142. http://dx.doi.org/10.1016/j.ymgme.2009.02.003

30. Silvain M, Bligny D, Aparicio T, Laforêt P, Grodet A, Peretti N, Ménard D, Djouadi F, Jardel C, Bégué JM, Walker F, Schmitz J, Lachaux A, Aggerbeck LP, Samson-Bouma ME. Anderson's disease (chylomicron retention disease): a new mutation in the SARA2 gene associated with muscular and cardiac abnormalities. Clin Genet 2008;74:546-552 http://dx.doi.org/10.1111/j.1399-0004.2008.01069.x

31. Rahalkar AR, Hegele RA. Monogenic pediatric dyslipidemias: classification, genetics and clinical spectrum. Mol Genet Metab 2008;93:282-294. http://dx.doi.org/10.1016/j.ymgme.2007.10.007

32. von Eckardstein A. Differential diagnosis of familial high density lipoprotein deficiency syndromes. Atherosclerosis 2006;186:231-239. http://dx.doi.org/10.1016/j.atherosclerosis.2005.10.033

33. Kastelein JJ, Pritchard PH, Erkelens DW, Kuivenhoven JA, Albers JJ, Frohlich JJ. Familial high-density-lipoprotein deficiency causing corneal opacities (fish eye disease) in a family of Dutch descent. J Intern Med 1992;231:413-419. http://dx.doi.org/10.1111/j.1365-2796.1992.tb00953.x

34. Bourcier T, Chibane S, Boutboul S, Abitbol M, Borderie V, Laroche L, Héron E. Fish eye disease revealing a partial LCAT deficiency. Rev Med Interne 2005;26:518-519. http://dx.doi.org/10.1016/j.revmed.2004.11.010

35. Jahanzad I, Amoueian S, Attaranzadeh A. Familial lecithincholesterol acyltransferase deficiency. Arch Iran Med 2009;12:179-181.

36. Calabresi L, Pisciotta L, Costantin A, Frigerio I, Eberini I, Alessandrini P, et al. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol 2005;25:1972-1978. http://dx.doi.org/10.1161/01.ATV.0000175751.30616.13

37. Yee MS, Pavitt DV, Richmond W, Cook HT, McLean AG, Valabhji J, Elkeles RS. Changes in lipoprotein profile and urinary albumin excretion in familial LCAT deficiency with lipid lowering therapy. Atherosclerosis 2009;205:528-532. http://dx.doi.org/10.1016/j.atherosclerosis.2008.11.033

Kaynak Göster

925 453

Arşiv
Sayıdaki Diğer Makaleler

Silmarin nöroblastom hücrelerinde pro-inflamatuvar sitokin üretimini düzenleyerek sisplatin ile birlikte hücre ölümünü etkiler mi?

ZEKİYE SULTAN ALTUN, Emre ÇEÇEN, Ayça PAMUKOĞLU, SAFİYE AKTAŞ, HATİCE NUR OLGUN

Anne ve babalar çocukların olduğu ortamlarda sigara içmekten neden kaçınmazlar?

DİLEK ASLAN, Ekin KOÇ, Elif Nursel ÖZMERT, Songül VAZİOĞLU ACAR

Hipo/hiperkalsemi ile giden subkutan yağ dokusu nekrozu ve brakiyal pleksopati

Sevgi YİMENİCİOĞLU, Mehmet Fatih YİMENİCİOĞLU, AHMET TÜRKELİ, Arzu EKİCİ, Demet AÇIKALIN, Veysel Nijat BAŞ

Evaluation of endothelial function and platelet activation in dyslipidemic children

Sema UÇAR KALKAN, Yasemin Delen AKÇAY, Turan KOLOĞLU, Ertürk LEVENT, ESER YILDIRIM SÖZMEN, Mahmut ÇOKER

Çocuk hastalarda klasik ve ProSeal laringeal maske (LMA) karşılaştırılması

Gürcan GÜNGÖR, Pervin BOZKURT SUTAŞ, LALE YÜCEYAR

Çocuklarda hipolipidemiler

Cahit Barış ERDUR, Yiğithan GÜZİN

Sütçocuklarında atopik dermatit ağırlığı ile serum TSLP ve TARC düzeyleri arasındaki ilişki

Fatih BİRTEKOCAK, Pınar UYSAL, ASLIHAN BÜYÜKÖZTÜRK KARUL

Neonatal hiperekpleksia: Bir olgu sunumu

Erhan ÇALIŞICI, Hamdi OĞRAĞ, Belma KARAGÖL SAYGILI

Çocuğun cinsel istismarının değerlendirilmesinde yeni model: Çocuk İzlem Merkezleri

Özlem BAĞ, Sevay ALŞEN

Erzurum ilinde 1-18 yaş çocuklarda histopatolojik olarak Helicobacter pylori sıklığı

Şenay DURMUŞ ERDOĞAN, Hilal BALTA, Sevilay ÖZMEN AKALP, Ali KURT, İLKNUR ÇALIK, Ahmet Erkan BİLİCİ, FAZLI ERDOĞAN